Freeport-McMoRan (FCX) insider files Form 144 to sell 28,423 shares
Rhea-AI Filing Summary
Freeport-McMoRan (FCX) insider plans to sell common stock under Rule 144. A holder filed a notice to sell 28,423 shares of common stock through broker Charles Schwab on or about 12/11/2025 on the NYSE, with an aggregate market value of $1,363,451.31.
The shares were originally acquired on 02/15/2023 as a restricted stock award from the issuer, designated as equity compensation. Shares outstanding were 1,435,930,660 at the time of the notice; this is a baseline figure, not the amount being sold.
Positive
- None.
Negative
- None.
FAQ
What does this Form 144 filing mean for Freeport-McMoRan (FCX)?
This notice indicates that an affiliated holder of Freeport-McMoRan (FCX) plans to sell 28,423 common shares under Rule 144. It is a regulatory disclosure of an intended sale, not a company-level capital raise or new issuance.
How many Freeport-McMoRan (FCX) shares are planned to be sold and at what value?
The filer plans to sell 28,423 shares of FCX common stock with an aggregate market value of $1,363,451.31, according to the notice.
When are the FCX shares expected to be sold under this Form 144?
The notice lists an approximate sale date of 12/11/2025 for the planned sale of 28,423 FCX common shares.
How were the Freeport-McMoRan (FCX) shares being sold acquired?
The 28,423 FCX common shares were acquired on 02/15/2023 as a restricted stock award from the issuer, classified as equity compensation.
Which broker and exchange are involved in this FCX Rule 144 sale?
The planned sale will be executed through Charles Schwab Corp. as broker, and the securities are listed for trading on the NYSE.
How does the planned FCX share sale compare to total shares outstanding?
At the time of the notice, there were 1,435,930,660 FCX common shares outstanding. The planned sale of 28,423 shares is small relative to this baseline figure.